top of page

News

Oct 26, 2023

First Annual CRISPR Cures for Cancer Symposium

On November 9, 2023, investigators from the CRISPR Cures for Cancer network will present their latest work. Learn how they apply cutting-edge technologies to the design and development of novel therapeutic approaches for cancer.

First Annual CRISPR Cures for Cancer Symposium

Sep 18, 2023

CRISPR Cures for Cancer 2023 RFP Awardees Announced

The first cohort of investigators selected for project funding through the CRISPR Cures for Cancer Initiative were chosen this past July and include researchers at UCSF, Gladstone Institutes, and the Innovative Genomics Institute at UC Berkeley.

CRISPR Cures for Cancer 2023 RFP Awardees Announced

Sep 14, 2023

Lego-Like Gene Editing Tool Lets Researchers Improve Cancer Immunotherapy

Scientists used a new method to screen 10,000 combinations of gene edits in immune cells engineered to fight cancer.

Lego-Like Gene Editing Tool Lets Researchers Improve Cancer Immunotherapy

Aug 30, 2023

How Unique Immune Cells Can Recognize—and Destroy—Tumors

A new study explains how understudied cells in the immune system, called gamma delta T cells, can target cancer cells for destruction.

How Unique Immune Cells Can Recognize—and Destroy—Tumors

Jan 25, 2023

The Race to Supercharge Cancer-Fighting T Cells

With a slew of tools to trick out immune cells, researchers are expanding the repertoire of CAR-T therapies.

The Race to Supercharge Cancer-Fighting T Cells

Dec 7, 2022

Re-engineering the Human Immune System

Researchers at the Gladstone-UCSF Institute of Genomic Immunology are learning how to harness the power of the human immune system in new ways.

Re-engineering the Human Immune System

Nov 10, 2022

“CAR Pooling” Screens Identify Most Effective Cancer Immunotherapy Cells

A new approach by UCSF researchers analyzes how well different re-engineered T cells work against cancer.

“CAR Pooling” Screens Identify Most Effective Cancer Immunotherapy Cells

Aug 25, 2022

A Cellular Engineering Breakthrough: High-Yield CRISPR Without Viral Vectors

A team of scientists at Gladstone and UCSF developed a new approach using CRISPR to produce massive quantities of cells for therapeutic applications.

A Cellular Engineering Breakthrough: High-Yield CRISPR Without Viral Vectors

Aug 24, 2022

Giving Immunotherapy Cells Resilience to Pass the “Stress Test”

A gene not previously known to regulate immunity could turn tired T cells around.

Giving Immunotherapy Cells Resilience to Pass the “Stress Test”

Apr 15, 2022

A New Toolkit To Engineer Safe and Efficient Therapeutic Cells

Kole Roybal and his team developed a comprehensive rule book for the design of therapeutic cells with improved specificity and safety, and for the eventual customization of cell-based therapies.

A New Toolkit To Engineer Safe and Efficient Therapeutic Cells
bottom of page